JavaScript is off. Please enable to view full site.

Japan's JCR Pharma to build new plant to produce COVID-19 vaccine solution

Thursday, March 04, 2021, 16:29 GMT+7
Japan's JCR Pharma to build new plant to produce COVID-19 vaccine solution
A medical worker receives a dose of the coronavirus disease (COVID-19) vaccine as the country launches its inoculation campaign, in Tokyo, Japan February 17, 2021. Photo: Behrouz Mehri/Pool via Reuters

TOKYO -- JCR Pharmaceuticals Co said on Thursday it would build a new plant in Japan to expand production of ingredients for COVID-19 vaccines over the longer term.

JCR Pharma along with Daiichi Sankyo Co and other Japanese partners are cooperating to produce and distribute the COVID-19 vaccine developed by AstraZeneca Plc and Oxford University. The Japanese government has arranged to buy 120 million doses of the vaccine, which was submitted to domestic regulators for approval on Feb. 5.

JCR Pharma said in a statement that it has been making bulk substances for the vaccine at an existing plant but will build another one to comply with government requirements.

The Japanese drugmaker signed a contract in December to make substances for the AstraZeneca vaccine. But as a condition for a government grant to reinforce the country’s vaccine production capability through 2030, it needed to build another facility.

JCR said it will spend about 11.6 billion yen ($108.28 million) to build the facility in Kobe City, western Japan, with construction due to start in July and finish by October 2022.

The AstraZeneca vaccine is a critical component in Japan’s inoculation plan, as the doses will be made mostly in the country, and don’t need to be stored at the ultra-cold temperatures required for Pfizer Inc’s COVID-19 vaccine.

Japan kicked off its COVID-19 inoculation campaign in the middle of February using Pfizer’s vaccine, the first to be approved by Japanese regulators. But the Pfizer doses have been imported from European factories and are in short supply.

Local media has reported that Moderna Inc will file for approval of its vaccine as early as Friday via its Japanese partner Takeda Pharmaceutical Co.

Reuters

More

Read more

;

Photos

VIDEOS

Vietnam’s Mekong Delta celebrates spring with ‘hat boi’ performances

The art form is so popular that it attracts people from all ages in the Mekong Delta

Vietnamese youngster travels back in time with clay miniatures

Each work is a scene caught by Dung and kept in his memories through his journeys across Vietnam

Experience summer sand-boarding in Mui Ne

Sand-boarding, a popular activity amongst local children in the coastal tourism town of Mui Ne in south-central Vietnam, is attracting hundreds of tourists to the Red Sand Dunes

Young maple trees given better protection as Hanoi enters rainy season

The trees are currently growing well, with green leaves and healthy branches.

Hunting skinks for food in southern Vietnam

Skink meat is known to be soft, tasty, and highly nutritious.

Latest news